Prince Henry's Institute of Medical Research, Clayton, Victoria, Australia.
Biotechniques. 2012 Jan;52(1):23-8. doi: 10.2144/000113798.
Mammalian high temperature requirement A3 (HtrA3) is a serine protease of the HtrA family. It is an important factor for placental development and a tumor suppressor. The biochemical properties of HtrA3 are uncharacterized. One critical step in biochemical characterization is overexpressing and purifying the full-length recombinant protein. However, utility of cell-based expression systems is limited for a protease because of autocleavage. The wheat-germ cell-free translation system is highly efficient at producing "difficult" eukaryotic multidomain proteins and is easily modifiable for protein synthesis at different temperatures. In this study, we evaluated the potential of the wheat-germ cell-free translation system for producing human HtrA3. HtrA3 underwent autocleavage when synthesized at 17 °C. When the synthesis temperature was lowered to 4 °C, full-length HtrA3 was successfully produced and proteolytically active. Catalytic site serine substitution with alanine (S305A) stabilized HtrA3 while abolishing its protease activity. This mutant was readily synthesized and stable at 17 °C. When used with glutathione S-transferase (GST) pull-down assay, S305A HtrA3 was a valuable bait in searching for endogenous HtrA3 binding proteins. Thus, we demonstrated the unique utility of the wheat-germ cell-free translation system for producing and characterizing human HtrA3. These strategies will be likely applicable to a wide range of proteases.
哺乳动物高温需求 A3(HtrA3)是 HtrA 家族的丝氨酸蛋白酶。它是胎盘发育的重要因素和肿瘤抑制因子。HtrA3 的生化特性尚未确定。生化特性分析的一个关键步骤是过表达和纯化全长重组蛋白。然而,由于自身切割,基于细胞的表达系统对于蛋白酶的应用是有限的。小麦胚细胞无细胞翻译系统在生产“困难”的真核多结构域蛋白方面非常高效,并且易于在不同温度下进行蛋白质合成的修饰。在这项研究中,我们评估了小麦胚细胞无细胞翻译系统生产人 HtrA3 的潜力。HtrA3 在 17°C 时合成时会发生自身切割。当合成温度降低到 4°C 时,全长 HtrA3 成功合成并具有蛋白水解活性。催化位点丝氨酸突变为丙氨酸(S305A)稳定了 HtrA3,同时消除了其蛋白酶活性。该突变体在 17°C 时易于合成且稳定。当与谷胱甘肽 S-转移酶(GST)下拉测定一起使用时,S305A HtrA3 是寻找内源性 HtrA3 结合蛋白的有价值的诱饵。因此,我们证明了小麦胚细胞无细胞翻译系统在生产和表征人 HtrA3 方面的独特用途。这些策略可能适用于广泛的蛋白酶。